| 12486312 |
Immunomodulatory proteins with tunable affinities |
Ryan Swanson |
2025-12-02 |
|
| 12110339 |
ICOS ligand variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2024-10-08 |
|
| 11834490 |
CD112 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Daniel William DEMONTE, Mark F. Maurer, Dan ARDOUREL, Joseph L. Kuijper |
2023-12-05 |
$16,430,000 |
| 11732022 |
PD-L2 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Dan ARDOUREL, Daniel William DEMONTE, Joseph L. Kuijper |
2023-08-22 |
$9,022,000 |
| 11639375 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2023-05-02 |
$4,669,000 |
| 11613566 |
Variant ICOS ligand immunomodulatory proteins and related compositions and methods |
Lawrence Evans, Ryan Swanson |
2023-03-28 |
$4,826,000 |
| 11498967 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2022-11-15 |
$4,578,000 |
| 11479609 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2022-10-25 |
$3,739,000 |
| 11471488 |
CD155 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Daniel William DEMONTE, Mark F. Maurer |
2022-10-18 |
$4,172,000 |
| 11359022 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2022-06-14 |
$4,159,000 |
| 11319359 |
Immunomodulatory proteins with tunable affinities |
Ryan Swanson |
2022-05-03 |
$4,512,000 |
| 11230588 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2022-01-25 |
$4,204,000 |
| 11117948 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11117949 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11117950 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2021-09-14 |
$1,252,000 |
| 11096988 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson, Mark F. Maurer, Joseph L. Kuijper |
2021-08-24 |
$3,624,000 |
| 11078282 |
CD80 variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2021-08-03 |
$3,358,000 |
| 10882914 |
ICOS ligand variant immunomodulatory proteins and uses thereof |
Ryan Swanson |
2021-01-05 |
$12,352,000 |
| 9605024 |
PAR4 agonist peptides |
Claudio Mapelli, Douglas James Riexinger |
2017-03-28 |
|
| 9303065 |
PAR4 agonist peptides |
Claudio Mapelli, Douglas James Riexinger |
2016-04-05 |
|
| 8927688 |
PAR4 agonist peptides |
Claudio Mapelli, Douglas James Riexinger |
2015-01-06 |
$245,146,000 |
| 7713699 |
Methods of diagnosing colon adenocarcinoma using mRNA encoding the human g-protein coupled receptor, HGPRBMY23 |
John Feder, Thomas Nelson, Chandra Ramanathan, Rolf-Peter Ryseck |
2010-05-11 |
$48,176,000 |
| 7314726 |
Beta secretase exosite binding peptides and methods for identifying beta secretase modulators |
Robert A. Copeland, Joseph Hendrick, Zhihong Lai, Claudio Mapelli, Mark Witmer +4 more |
2008-01-01 |
|
| 6051381 |
Prokaryotic two-hybrid system |
— |
2000-04-18 |
|
